The once-monthly drug is still under study but could provide added convenience and another option for patients.

Maple sugar and honey are natural sweeteners with different health benefits. Learn more about their nutritional values and ...

Researchers found that once-monthly maridebart cafraglutide led to substantial weight loss and improved glycemic control in ...

Craig Beall currently receives funding from Diabetes UK, Breakthrough T1D ... This is because switching off excessive liver glucose production is the primary action of insulin to correct blood sugar ...

So-called ‘skinny jabs’ are being prescribed to people who don’t need them, with terrifying side effects. How did our ...

Polycystic Ovary Syndrome (PCOS) affects many women, leading to a variety of symptoms that can disrupt daily life. In recent ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes patients.

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

In a clinical trial led by University of Toronto researchers, an allogeneic stem cell–derived islet therapy (zimislecel) ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...